These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9031996)

  • 1. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.
    Poyurovsky M; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 1996 Dec; 11(4):283-6. PubMed ID: 9031996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: case reports.
    Miller CH; Hummer M; Pycha R; Fleischhacker WW
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Mar; 16(2):247-51. PubMed ID: 1349760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced akathisia in children with schizophrenia.
    Gogtay N; Sporn A; Alfaro CL; Mulqueen A; Rapoport JL
    J Child Adolesc Psychopharmacol; 2002; 12(4):347-9. PubMed ID: 12625995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of depression manifesting incessant pacing and wandering following discontinuation of antipsychotic drugs due to neuroleptic malignant syndrome: a possible involvement of withdrawal akathisia].
    Watanabe H; Terao T
    J UOEH; 1997 Mar; 19(1):29-38. PubMed ID: 9084097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose metoprolol in neuroleptic-induced akathisia.
    Kim A; Adler L; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1989 Aug; 9(4):294-6. PubMed ID: 2570088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
    Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
    Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs.
    Hermesh H; Molcho A; Munitz H
    Clin Neuropharmacol; 1988 Aug; 11(4):369-72. PubMed ID: 2905207
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
    Seppälä N; Kovio C; Leinonen E
    CNS Drugs; 2005; 19(12):1049-55. PubMed ID: 16332145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
    Lipinski JF; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 19. Second thoughts about clozapine as a treatment for neuroleptic-induced akathisia.
    Levine J; Chengappa KN
    J Clin Psychiatry; 1998 Apr; 59(4):195. PubMed ID: 9590672
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.
    Shiovitz TM; Welke TL; Tigel PD; Anand R; Hartman RD; Sramek JJ; Kurtz NM; Cutler NR
    Schizophr Bull; 1996; 22(4):591-5. PubMed ID: 8938913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.